Fidia S.p.A. (BIT:FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 366.89K |
| Revenue (ttm) | 29.17M |
| Net Income (ttm) | -6.44M |
| Shares Out | 31.09M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,063,967 |
| Average Volume | 11,559,795 |
| Open | 0.0126 |
| Previous Close | 0.0118 |
| Day's Range | 0.0112 - 0.0122 |
| 52-Week Range | 0.0108 - 0.8600 |
| Beta | 0.06 |
| RSI | 36.00 |
| Earnings Date | Mar 17, 2025 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
Financial StatementsNews
FDA staffers told that 'woman,' 'disabled' among banned words; White House says its an error: Reuters
A list with the file name "Prohibited words" has been circulating since at least last week, two FDA scientists with direct knowledge of the matter told Reuters.
Amneal Pharmaceuticals Launches Mesalamine Tablets and Secures FDA Approval for Lenalidomide ...
Amneal Pharmaceuticals Launches Mesalamine Tablets and Secures FDA Approval for Lenalidomide Capsules
PTC Therapeutics Announces FDA Priority Review for Vatiquinone NDA
PTC Therapeutics Announces FDA Priority Review for Vatiquinone NDA
Ionis Pharmaceuticals Reports Strong Q4 Earnings After Recent FDA Approval
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
On Wednesday, Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for excessive daytime sleepines...
Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug
Harmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition.
Gilead (GILD) Advances HIV Prevention Drug Lenacapavir with FDA Submission
Gilead (GILD) Advances HIV Prevention Drug Lenacapavir with FDA Submission
Harmony Biosciences's sleep disorder treatment gets FDA Refuse to File letter
Gilead Sciences Inc (GILD) Advances HIV Prevention with FDA Acceptance of Lenacapavir NDA
Gilead Sciences Inc (GILD) Advances HIV Prevention with FDA Acceptance of Lenacapavir NDA
Elon Musk’s company Neuralink reviewers fired amid FDA layoffs: Report
The US FDA has dismissed around 20 employees, impacting the review of Neuralink’s brain implant trials. The layoffs, part of a broader government spending cut led by Elon Musk, have raised concerns ov...
Ultragenyx Pharmaceutical Inc (RARE) Announces FDA Priority Review for UX111 Gene Therapy
Ultragenyx Pharmaceutical Inc (RARE) Announces FDA Priority Review for UX111 Gene Therapy
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla (NASDAQ: TSLA) Chief, Elon Musk ‘s private brain implant company, Neuralink , were dismissed over the weekend...
Teva Pharmaceutical Industries Ltd (TEVA) and Alvotech Announce FDA Review of Biosimilar Application
Teva Pharmaceutical Industries Ltd (TEVA) and Alvotech Announce FDA Review of Biosimilar Application
Alvotech's Biosimilar to Eylea® Receives FDA Review Acceptance
Alvotech's Biosimilar to Eylea® Receives FDA Review Acceptance
Aurobindo shares fall 7% as US FDA issues 5 observations on pre-approval inspection for Andhra unit
Shares of Aurobindo Pharma fell by 7% to ₹1,098.10 after the company disclosed that the U.S. Food and Drug Administration (US FDA) had issued five observations for its step-down subsidiary Eugia Steri...
Piramal Pharma shares drop 5% after US FDA issues Form-483 with 6 observations for Turbhe Facility
Piramal Pharma Limited’s shares fell 5% after the company received a Form-483 from the US FDA following an inspection of its Turbhe facility. The General GMP (Good Manufacturing Practices) audit, cond...
Regeneron Pharmaceuticals Inc (REGN) Announces FDA Priority Review for Dupixent in Treating ...
Regeneron Pharmaceuticals Inc (REGN) Announces FDA Priority Review for Dupixent in Treating Bullous Pemphigoid
Trump stumbles as Musks fraud claims come up empty
Donald Trump’s deep cuts to the federal government have now impacted the FDA, with similar layoffs and budget reductions expected to hit the Pentagon next. Reporting indicates these rushed efforts hav...
FDA's food safety head resigns over mass layoffs
Jim Jones, the former head of the Food and Drug Administration’s food division, resigned on Monday, citing the mass firings of agency staff. According to a copy of his resignation letter viewed by The...
Merus Shares Are Up Today: What's Going On?
Shares of Merus N.V. (NASDAQ: MRUS) are trading higher Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to petosemtamab in combination with pem...
DOGE reportedly fired the FDA employees who were reviewing clinical trials for Elon Musk’s Neuralink
The FDA approved human clinical trials for Neuralink’s brain implants in May 2023.
Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments
FDA finds three guilty of selling poor quality nuts
Calangute: The Food and Drugs Administration (FDA) conducted raids on shops selling cashew nuts at Calangute and Baga on Tuesday as part of the ongoin.
Leader of FDA food division resigns
Jim Jones, head of the FDA's food division, has resigned. The division is tasked with ensuring the safety of the U.S. food supply, overseeing inspections and recalls.